Calcium controlled activation of platelets via electrical stimulation
The present disclosure relates to the generation of an activated platelet product in which one or more of the presence or absence of clots, the timing of clot formation (if present), and/or the mechanical strength of clots (if present) is controlled by the presence or concentration of calcium ions during the activation process. In certain embodiments, the calcium ion concentration is controlled in the presence of pulsed electric fields or a chemical activator (e.g., thrombin) as part of the activation process.
1. A method for generating an activated product composition comprising:
preparing an anticoagulant-treated platelet-rich plasma (PRP) sample for activation;
adding calcium ions to the PRP sample to achieve a calcium ion concentration selected from a range of concentrations, wherein the calcium ion concentration is selected based upon a target growth factor profile of a plurality of growth factors to be present in an activated product composition generated using the PRP sample and one or more clotting characteristics to be present in the activated product composition; and
exposing the PRP sample to one or more electrical pulses, wherein the PRP sample, when exposed to the one or more electrical pulses, yields an activated product composition comprising the target growth factor profile of the plurality of growth factors.
2. The method of claim 1 , further comprising specifying a set of electrical pulse parameters to be used in generating the one or more electrical pulses.
3. The method of claim 1 , wherein adding calcium ions to the PRP sample comprises adding CaCl 2 to the PRP sample in a concentration in the range of 2.5 mM to 25 mM.
4. The method of claim 3 , wherein the concentration of calcium ions is selected from 2.5 mM, 5.0 mM, 7.5 mM, 10 mM, 15 mM, 20 mM, or 25 mM CaCl2 being added to the PRP sample.
5. The method of claim 1 , wherein varying the calcium ion concentration generates an additional calcium ion concentration that differs from the calcium ion concentration.
6. The method of claim 5 , further comprising determining that when the calcium ion concentration is less than the additional calcium ion concentration, an initial clot formation is observed as being quicker at the additional calcium ion concentration.
7. The method of claim 5 , further comprising determining that when the calcium ion concentration is less than the additional calcium ion concentration a clot mechanical strength results that is less than that observed at the second calcium ion concentration.
8. The method of claim 1 , wherein the PRP sample comprises at least one of a platelet rich plasma sample, a platelet suspension, or a whole blood sample.
9. The method of claim 1 , wherein the target growth factor profile represents relative amounts of the plurality of growth factors with respect to one another as compared to what is generated using thrombin.
10. The method of claim 1 , wherein the one or more clotting characteristics comprise a clotting strength, a clotting time, or both.
11. A method for controlling clot mechanical strength in a platelet gel, comprising:
determining a prospective mechanical strength of one or more clots to be generated in the platelet gel, wherein the prospective mechanical strength is greater than what would be observed by generating the platelet gel using thrombin alone;
based on the prospective mechanical strength, selecting a calcium ion concentration corresponding to the prospective mechanical strength from among a plurality of calcium ion concentrations;
generating the platelet gel by activating a platelet-rich plasma (PRP) sample comprising calcium ions at the selected calcium ion concentration, wherein the PRP sample is activated using electrical stimulus, and wherein the platelet gel comprises clots that, once formed, have the prospective mechanical strength.
12. The method of claim 11 , wherein, for the plurality of calcium ion concentrations, higher calcium ion concentrations correspond to greater mechanical strength of the clots.
13. The method of claim 11 , wherein the calcium ion concentration is selected from the plurality of concentrations corresponding to 2.5 mM, 5.0 mM, 7.5 mM, 10 mM, 15 mM, 20 mM, or 25 mM CaCl 2 being added to the PRP sample.